In this study, we set out to first examine the expression and significance of several immune cell‐related markers including PD‐L1 and PD‐1, as well as nuclear β‐catenin‐related tumor budding features, during tumor progression in CRC without NCRT. The gene discussed is CD274; the disease is neoplasm.